Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Gains from Sales and Divestitures: 2011-2013

  • Lifecore Biomedical's Gains from Sales and Divestitures was N/A to -$37,000 in Q2 2013 from the same period last year, while for May 2011 it was $26,000, marking a year-over-year change of. This contributed to the annual value of -$217,000 for FY2013, which is 1708.33% down from last year.
  • Lifecore Biomedical's Gains from Sales and Divestitures amounted to -$37,000 in Q2 2013, which was up 79.44% from -$180,000 recorded in Q3 2012.
  • In the past 5 years, Lifecore Biomedical's Gains from Sales and Divestitures ranged from a high of $26,000 in Q2 2011 and a low of -$180,000 during Q3 2012.
  • Its 3-year average for Gains from Sales and Divestitures is -$63,667, with a median of -$37,000 in 2013.